Alterations of host-gut microbiome interactions in multiple sclerosis
Claudia Cantoni,
Qingqi Lin,
Yair Dorsett,
Laura Ghezzi,
Zhongmao Liu,
Yeming Pan,
Kun Chen,
Yanhui Han,
Zhengze Li,
Hang Xiao,
Matthew Gormley,
Yue Liu,
Suresh Bokoliya,
Hunter Panier,
Cassandra Suther,
Emily Evans,
Li Deng,
Alberto Locca,
Robert Mikesell,
Kathleen Obert,
Pamela Newland,
Yufeng Wu,
Amber Salter,
Anne H. Cross,
Phillip I. Tarr,
Amy Lovett-Racke,
Laura Piccio,
Yanjiao Zhou
Affiliations
Claudia Cantoni
Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA
Qingqi Lin
Department of Computer Science and Engineering, University of Connecticut, Storrs, CT, USA
Yair Dorsett
Department of Medicine, UConn Health, Farmington, CT, USA
Laura Ghezzi
Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA; Dino Ferrari Center, University of Milan, Milan, Italy
Zhongmao Liu
Department of Statistics, University of Connecticut, Storrs, CT USA
Yeming Pan
Department of Statistics, University of Connecticut, Storrs, CT USA
Kun Chen
Department of Statistics, University of Connecticut, Storrs, CT USA
Yanhui Han
Department of Food Science, University of Massachusetts, Amherst, Massachusetts USA
Zhengze Li
Department of Food Science, University of Massachusetts, Amherst, Massachusetts USA
Hang Xiao
Department of Food Science, University of Massachusetts, Amherst, Massachusetts USA
Matthew Gormley
Department of Microbial Infection and Immunity, Ohio State University, Columbus, OH, USA
Yue Liu
Department of Microbial Infection and Immunity, Ohio State University, Columbus, OH, USA
Suresh Bokoliya
Department of Medicine, UConn Health, Farmington, CT, USA
Hunter Panier
Department of Medicine, UConn Health, Farmington, CT, USA
Cassandra Suther
Department of Food Science, University of Massachusetts, Amherst, Massachusetts USA
Emily Evans
Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA
Li Deng
Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA; Department of Anesthesiology, First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, China
Alberto Locca
Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA
Robert Mikesell
Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA
Kathleen Obert
Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA
Pamela Newland
Barnes Jewish College, Goldfarb School of Nursing, St. Louis, MO, USA
Yufeng Wu
Department of Computer Science and Engineering, University of Connecticut, Storrs, CT, USA
Amber Salter
Division of Biostatistics, School of Medicine, Washington University, St. Louis, MO, USA
Anne H. Cross
Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA; Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, MO 63110, USA
Phillip I. Tarr
Departments of Pediatrics and Molecular Microbiology, Washington University School of Medicine, St. Louis, MO, USA
Amy Lovett-Racke
Department of Microbial Infection and Immunity, Ohio State University, Columbus, OH, USA
Laura Piccio
Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA; Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, MO 63110, USA; Brain and Mind Centre, School of Medical Sciences, University of Sydney, Sydney, NSW 2050, Australia; Corresponding authors.
Yanjiao Zhou
Department of Medicine, UConn Health, Farmington, CT, USA; Corresponding authors.
Summary: Background: Multiple sclerosis (MS) has a complex genetic, immune and metabolic pathophysiology. Recent studies implicated the gut microbiome in MS pathogenesis. However, interactions between the microbiome and host immune system, metabolism and diet have not been studied over time in this disorder. Methods: We performed a six-month longitudinal multi-omics study of 49 participants (24 untreated relapse remitting MS patients and 25 age, sex, race matched healthy control individuals. Gut microbiome composition and function were characterized using 16S and metagenomic shotgun sequencing. Flow cytometry was used to characterize blood immune cell populations and cytokine profiles. Circulating metabolites were profiled by untargeted UPLC-MS. A four-day food diary was recorded to capture the habitual dietary pattern of study participants. Findings: Together with changes in blood immune cells, metagenomic analysis identified a number of gut microbiota decreased in MS patients compared to healthy controls, and microbiota positively or negatively correlated with degree of disability in MS patients. MS patients demonstrated perturbations of their blood metabolome, such as linoleate metabolic pathway, fatty acid biosynthesis, chalcone, dihydrochalcone, 4-nitrocatechol and methionine. Global correlations between multi-omics demonstrated a disrupted immune-microbiome relationship and a positive blood metabolome-microbiome correlation in MS. Specific feature association analysis identified a potential correlation network linking meat servings with decreased gut microbe B. thetaiotaomicron, increased Th17 cell and greater abundance of meat-associated blood metabolites. The microbiome and metabolome profiles remained stable over six months in MS and control individuals. Interpretation: Our study identified multi-system alterations in gut microbiota, immune and blood metabolome of MS patients at global and individual feature level. Multi-OMICS data integration deciphered a potential important biological network that links meat intakes with increased meat-associated blood metabolite, decreased polysaccharides digesting bacteria, and increased circulating proinflammatory marker. Funding: This work was supported by the Washington University in St. Louis Institute of Clinical and Translational Sciences, funded, in part, by Grant Number # UL1 TR000448 from the National Institutes of Health, National Center for Advancing Translational Sciences, Clinical and Translational Sciences Award (Zhou Y, Piccio, L, Lovett-Racke A and Tarr PI); R01 NS10263304 (Zhou Y, Piccio L); the Leon and Harriet Felman Fund for Human MS Research (Piccio L and Cross AH). Cantoni C. was supported by the National MS Society Career Transition Fellowship (TA-180531003) and by donations from Whitelaw Terry, Jr. / Valerie Terry Fund. Ghezzi L. was supported by the Italian Multiple Sclerosis Society research fellowship (FISM 2018/B/1) and the National Multiple Sclerosis Society Post-Doctoral Fellowship (FG-190734474). Anne Cross was supported by The Manny & Rosalyn Rosenthal-Dr. John L. Trotter MS Center Chair in Neuroimmunology of the Barnes-Jewish Hospital Foundation. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.